We have located links that may give you full text access.
Journal Article
Review
Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.
European Journal of Nuclear Medicine and Molecular Imaging 2023 August 11
PURPOSE: Transthyretin (ATTR) amyloidosis is a progressive protein misfolding disease with frequent cardiac involvement. This review aims to determine the value of PET in diagnosis, assessment of disease progression or treatment response and its relation to clinical outcome in follow-up of ATTR amyloid cardiomyopathy (ATTR-CM) patients.
METHODS: Medline, Cochrane Library, Embase and Web of Science databases were searched, from the earliest date available until December 2022, for studies investigating the use of PET in ATTR-CM patients. Studies containing original data were included, except for case reports. Risk of bias was assessed by QUADAS-2.
RESULTS: Twenty-one studies were included in this systematic review, investigating five different tracers: carbon-11 Pittsburgh compound B ([11 C]PIB), fluorine-18 Florbetaben ([18 F]FBB), fluorine-18 Florbetapir ([18 F]FBP), fluorine-18 Flutemetamol ([18 F]FMM) and fluorine-18 Sodium Fluoride (Na[18 F]F). In total 211 ATTR amyloidosis patients were included. A majority of studies concluded that [11 C]PIB, [18 F]FBP and Na[18 F]F can distinguish ATTR amyloidosis patients from controls, and that [11 C]PIB and Na[18 F]F, but not [18 F]FBP, can distinguish ATTR-CM patients from patients with cardiac light chain amyloidosis. Evidence on the performance of [18 F]FBB and [18 F]FMM was contradictory. No studies on the use of PET in follow-up were found.
CONCLUSION: [11 C]PIB, Na[18 F]F and [18 F]FBP can be used to diagnose cardiac amyloidosis, although [18 F]FBP may not be suitable for the distinction of different types of amyloid cardiomyopathy. No studies on PET in the follow-up of ATTR amyloidosis patients were found. Future research should focus on the use of these PET tracers in the follow-up of ATTR amyloidosis patients.
METHODS: Medline, Cochrane Library, Embase and Web of Science databases were searched, from the earliest date available until December 2022, for studies investigating the use of PET in ATTR-CM patients. Studies containing original data were included, except for case reports. Risk of bias was assessed by QUADAS-2.
RESULTS: Twenty-one studies were included in this systematic review, investigating five different tracers: carbon-11 Pittsburgh compound B ([11 C]PIB), fluorine-18 Florbetaben ([18 F]FBB), fluorine-18 Florbetapir ([18 F]FBP), fluorine-18 Flutemetamol ([18 F]FMM) and fluorine-18 Sodium Fluoride (Na[18 F]F). In total 211 ATTR amyloidosis patients were included. A majority of studies concluded that [11 C]PIB, [18 F]FBP and Na[18 F]F can distinguish ATTR amyloidosis patients from controls, and that [11 C]PIB and Na[18 F]F, but not [18 F]FBP, can distinguish ATTR-CM patients from patients with cardiac light chain amyloidosis. Evidence on the performance of [18 F]FBB and [18 F]FMM was contradictory. No studies on the use of PET in follow-up were found.
CONCLUSION: [11 C]PIB, Na[18 F]F and [18 F]FBP can be used to diagnose cardiac amyloidosis, although [18 F]FBP may not be suitable for the distinction of different types of amyloid cardiomyopathy. No studies on PET in the follow-up of ATTR amyloidosis patients were found. Future research should focus on the use of these PET tracers in the follow-up of ATTR amyloidosis patients.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app